Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Oct 19, 2024; 14(10): 1467-1473
Published online Oct 19, 2024. doi: 10.5498/wjp.v14.i10.1467
Published online Oct 19, 2024. doi: 10.5498/wjp.v14.i10.1467
Relationship between serum neutrophil gelatinase-associated lipocalin levels and cognitive impairment, anxiety, and depressive symptoms in acute ischemic stroke
You-Quan Gu, Li-He Yao, Qiang Wang, Chao-Ning Zhou, Zhao-Dong Liu, Department of Neurology, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
Xuan Zhou, Department of Neurology, The First Clinical Medical College of Lanzhou University, Lanzhou 730099, Gansu Province, China
Author contributions: Gu YQ conceived the project; Zhou X, Yao LH, and Wang Q collected and analyzed the data; Gu YQ and Zhou CN wrote the first draft of the manuscript; Liu ZD provided expert suggestions and revised the manuscript. All authors contributed to the article and approved the submitted version.
Supported by Gansu Provincial Natural Science Foundation , No. 20JR10RA671 ; and The Fund of the First Hospital of Lanzhou University , No. ldyyyn2021-103 .
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the First Hospital of Lanzhou University, Approval No. LZ-009.
Informed consent statement: The patient/participant provided written informed consent to participate in this study. The publication of any potentially identifiable data included in this article has obtained the individual’s written informed consent.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: You-Quan Gu, MM, Chief Physician, Department of Neurology, The First Hospital of Lanzhou University, No. 1 Donggang West Road, Chengguan District, Lanzhou 730000, Gansu Province, China. guyq@lzu.edu.cn
Received: August 6, 2024
Revised: August 31, 2024
Accepted: September 14, 2024
Published online: October 19, 2024
Processing time: 72 Days and 0.6 Hours
Revised: August 31, 2024
Accepted: September 14, 2024
Published online: October 19, 2024
Processing time: 72 Days and 0.6 Hours
Core Tip
Core Tip: This study reveals the relationship between serum neutrophil gelatinase-associated lipocalin (NGAL) levels at admission and neuropsychiatric complications, including cognitive impairment, anxiety, and depressive symptoms, in patients with acute ischemic stroke (AIS). The findings indicate that higher NGAL levels are significantly associated with these complications. NGAL can serve as a potential biomarker for early identification of patients with AIS at risk for neuropsychiatric issues, enabling timely interventions and improved outcomes. This study highlights NGAL’s multifaceted roles in AIS-related neuropsychiatric complications and its potential therapeutic implications.